• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Deutsche Telekom bulks up T-Mobile US stake as it sells Dutch unit

September 7, 2021 by David Barret Leave a Comment

September 7, 2021

BERLIN (Reuters) – Deutsche Telekom struck a share-swap deal with Softbank to increase its stake in U.S. unit T-Mobile and sold its Dutch unit in a major restructuring of interests that strengthens the German group’s transatlantic focus.

As a result of the two deals announced on Tuesday, Deutsche Telekom will raise its stake in T-Mobile US by 5.3% to 48.4%, bringing CEO Tim Hoettges closer towards his goal of securing direct majority control over the U.S. telecoms operator.

Softbank will in return receive a 4.5% stake in Deutsche Telekom, establishing a direct shareholding relationship after Softbank sold its U.S. Sprint unit to T-Mobile in a deal that closed in early 2020.

In a separate deal, Deutsche Telekom sold its Dutch unit T-Mobile Netherlands to a consortium of private equity houses Apax and Warburg Pincus for 5.1 billion euros ($6.05 billion).

Deutsche Telekom acquired control of the Dutch business from Sweden’s Tele2 in 2018 but never considered the unit, which ranked a distant third behing market leaders KPN and Vodafone Ziggo, as a core asset.

Deutsche Telekom will invest some of its 3.8 billion euros in proceeds from the Dutch deal to raise its stake in T-Mobile US. Sweden’s Tele2 , which had retained a 25% stake in T-Mobile Netherlands, also sold out.

($1 = 0.8425 euros)

(Reporting by Douglas Busvine; Editing by Emma Thomasson and Kim Coghill)

Source Link Deutsche Telekom bulks up T-Mobile US stake as it sells Dutch unit

David Barret
David Barret

Related posts:

  1. Hackers are hiring more English speakers to write believable email scams
  2. JBL Quantum 350 looks like a great affordable wireless gaming headset
  3. Canada trade surplus narrowed in July to C$778 million
  4. Life insurers shift to pre-pandemic norms after COVID vaccine roll-outs

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • US Just Killed NASA’s Mars Sample Return Mission – So What Happens Now?
  • Art Sleuths May Have Recovered Traces Of Da Vinci’s DNA From One Of His Drawings
  • Countries With The Most Narcissists Identified By 45,000-Person Study, And The Results Might Surprise You
  • World’s Oldest Poison Arrows Were Used By Hunters 60,000 Years Ago
  • The Real Reason You Shouldn’t Eat (Most) Raw Cookie Dough
  • Antarctic Scientists Have Just Moved The South Pole – Literally
  • “What We Have Is A Very Good Candidate”: Has The Ancestor Of Homo Sapiens Finally Been Found In Africa?
  • Europe’s Missing Ceratopsian Dinosaurs Have Been Found And They’re Quite Diverse
  • Why Don’t Snorers Wake Themselves Up?
  • Endangered “Northern Native Cat” Captured On Camera For The First Time In 80 Years At Australian Sanctuary
  • Watch 25 Years Of A Supernova Expanding Into Space Squeezed Into This 40-Second NASA Video
  • “Diet Stacking” Trend Could Be Seriously Bad For Your Health
  • Meet The Psychedelic Earth Tiger, A Funky Addition To “10 Species To Watch” In 2026
  • The Weird Mystery Of The “Einstein Desert” In The Hunt For Rogue Planets
  • NASA Astronaut Charles Duke Left A Touching Photograph And Message On The Moon In 1972
  • How Multilingual Are You? This New Language Calculator Lets You Find Out In A Minute
  • Europa’s Seabed Might Be Too Quiet For Life: “The Energy Just Doesn’t Seem To Be There”
  • Amoebae: The Microscopic Health Threat Lurking In Our Water Supplies. Are We Taking Them Seriously?
  • The Last Dogs In Antarctica Were Kicked Out In April 1994 By An International Treaty
  • Interstellar Comet 3I/ATLAS Snapped By NASA’s Europa Mission: “We’re Still Scratching Our Heads About Some Of The Things We’re Seeing”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version